[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-356679-105":59,"doc-detail-356679-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","myc-bound-enhancer-rnas-in-cis-regulate-gene-transcription-and-tumorigenesis","MYC-bound enhancer RNAs in cis regulate gene transcription and tumorigenesis","","Emerging evidence indicates MYC binds RNAs, yet its functional impact on cancer gene regulation remains unclear. This study integrates multiomics analyses to show that MYC broadly associates with enhancer RNAs (eRNAs), which display high cancer- and tissue-specific expression across cancer cell lines and patient tumors. A computational pipeline predicts cis-regulatory MYC-eRNA target genes supported by RNA polymerase II–mediated chromatin interactions. The work functionally characterizes MERG1 as an oncogenic eRNA that promotes breast cancer tumorigenesis via MYC-enhanced occupancy at the GREB1 promoter, chromatin remodeling, and epigenetic activation, and demonstrates therapeutic suppression using nanoparticle-delivered antisense oligonucleotides targeting MERG1.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/myc-bound-enhancer-rnas-in-cis-regulate-gene-transcription-and-tumorigenesis/356679/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/myc-bound-enhancer-rnas-in-cis-regulate-gene-transcription-and-tumorigenesis/356679.png","ImageObject",300,407,{"name":92,"@type":93},"Taylor Morgan","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-07","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",15,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What does the study reveal about MYC binding in cancer cells?","Question",{"text":113,"@type":114},"MYC broadly binds enhancer RNAs (eRNAs), and these eRNAs show high cancer- and tissue-specific expression across cancer cell lines and patient tumors.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How are cis-regulatory MYC-eRNA target genes identified?",{"text":118,"@type":114},"The study builds a computational pipeline to predict cis-regulatory MYC-eRNA target genes, with most predicted eRNA-target pairs supported by RNA polymerase II–mediated chromatin interaction data.",{"name":120,"@type":111,"acceptedAnswer":121},"What is the role of MERG1 in breast cancer tumorigenesis?",{"text":122,"@type":114},"MERG1 functions as an oncogenic eRNA that interacts with MYC to enhance MYC occupancy at the GREB1 promoter, driving chromatin remodeling and epigenetic activation to amplify GREB1 expression and promote tumor progression.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},356679,1790616274,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":105,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1099523885336,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","CANCER  \nMYC-bound enhancer RNAs in cis regulate gene transcription and tumorigenesis  \nSihan Li1†, Zehua Wang1†*, Phuong Nguyen2,3,4, Yue Wang1, Yueshan Zhao1,  \nYifei Wang1, Yuang Chen1, Haozhe Huang1, Xiaofei Wang1, Yu Zhang1, Yixian Huang1, Dhamotharan Pattarayan1, Min Zhang1, Yang Liu2,3,4, Song Li1, Da Yang1,3*  \nEmerging evidence suggests that MYC binds RNAs, but its functional consequences remain unclear. Here, we integrate multiomics data and reveal that MYC broadly binds enhancer RNAs (eRNAs), which exhibit high cancer-and tissue-specific expression in cancer cell lines and patient tumors. Moreover, we developed a computational pipeline to identify potential cis-regulatory MYC-eRNA target genes, with most predicted eRNA-target pairs supported by RNA polymerase II–mediated chromatin interaction data. Among these, we functionally characterized MERG1 as an oncogenic eRNA that promotes breast cancer tumorigenesis. Mechanistically, MERG1 interacts with MYC to enhance its occupancy at the GREB1 promoter, driving chromatin remodeling and epigenetic activation. This process specifically amplifies GREB1 expression and promotes tumor progression. Last, nanoparticle-mediated delivery of antisense oligonucleotides targeting MERG1 suppresses MYC-mediated breast cancer growth. These results advance our understanding of the enhancer-driven regulation of gene expression and tumorigenesis and provide insights into the regulatory landscape of MYC in cancer.  \ncopyright © 2026 the Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. no claim to original U.S.  \nGovernment Works. distributed under a creative commons Attribution noncommercial License 4.0 (cc BY-nc) .  \nINTRODUCTION  \nEmerging evidence indicates that various types of noncoding RNAs are physically associated with chromatin and have essential regulatory functions in gene expression (1–3). For example, enhancer RNAs (eRNAs) can recruit RNA binding proteins (RBPs) to the enhancers and corresponding promoters to regulate the expression of their targets in cis (4). In addition to canonical RBPs, some transcription factors (TFs) or epigenetic modifiers can also interact with nascent RNAs transcribed from promoters and enhancers during transcription (5). It has been shown that eRNAs can directly recruit CBP/EP300 to specific enhancers and increase chromatin accessibility (6). In addition, eRNAs that interact with bromodomain-containing protein 4 (BRD4) are directly involved in gene regulation by modulating enhancer interactions and transcriptional functions of BRD4 (7).  \nAs a DNA binding TF, MYC dimerizes with MAX, and the MYC: MAX heterodimer binds to the E-box sequences near core promotersand enhancers to activate transcription (8–10) . In mammalian cells, MYC has been demonstrated to act as a transcriptional amplifier, binding to most transcriptionally activated promoters and further boosting gene expression ( 11, 12). However, during tumorigenesis, how MYC specifically dysregulates cancer-promoting genes has not been fully understood (13, 14) .  \nRecent studies have revealed that RNAs interact with MYC and regulate MYC protein stability and function. For example, Tseng et al. reported that long noncoding RNA (lncRNA) PVT1 can stabilize MYC protein expression ( 15) . We have also reported that lncRNA EPIC1 can increase MYC transcriptional activity (16). Further studies using both in vivo and in vitro RNA binding assays demonstrate that  \n1center for Pharmacogenetics, department of Pharmaceutical Sciences, University of Pittsburgh, Pittsburgh, PA, USA. 2department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA. 3UPMc hillman cancer institute, University of Pittsburgh, Pittsburgh, PA, USA. 4department of Bioengineering, department of electrical and computer engineering, cancer center at illinois, Beckman institute for Advanced Science and technology, University of illinois Urbana-champaign, Urbana, iL, USA.  \n*[corres","cbCaiplwvwKPuvGB","https://ap.wps.com/l/cbCaiplwvwKPuvGB","pdf",3331100,"English","# INTRODUCTION\n## MYC and enhancer RNA regulation in cancer\n# RESULTS\n## Characterization of MYC-bound eRNAs in cancer cell lines","[{\"question\":\"What does the study reveal about MYC binding in cancer cells?\",\"answer\":\"MYC broadly binds enhancer RNAs (eRNAs), and these eRNAs show high cancer- and tissue-specific expression across cancer cell lines and patient tumors.\"},{\"question\":\"How are cis-regulatory MYC-eRNA target genes identified?\",\"answer\":\"The study builds a computational pipeline to predict cis-regulatory MYC-eRNA target genes, with most predicted eRNA-target pairs supported by RNA polymerase II–mediated chromatin interaction data.\"},{\"question\":\"What is the role of MERG1 in breast cancer tumorigenesis?\",\"answer\":\"MERG1 functions as an oncogenic eRNA that interacts with MYC to enhance MYC occupancy at the GREB1 promoter, driving chromatin remodeling and epigenetic activation to amplify GREB1 expression and promote tumor progression.\"}]","MYC-bound enhancer RNAs in cis regulate gene transcription and tumorigenesis | PDF",1790126771,38,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d89677dc4d47b96fdc1f45ece5f50e88.webp",983,1250,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4e6bcc5402928ec06b29318d00155581.webp",982,1249,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/621a28e1a050517942530c9619fc5c7c.webp",981,1248,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7119a07925d0b4e7b785f6f3d3936f79.webp",980,1247]